Medicinal Mushroom Market Report 2025 (Global Edition)

Global Medicinal Mushroom Market Report 2025 Market Size Split by Type Outlook: (Reishi, Maitake, Chaga, Cordyceps, Turkey Tail, Others), by Form Outlook: (Fresh, Dried, Other), by Function Outlook: (...

Medicinal Mushroom Market Report Description

We have various report editions of Medicinal Mushroom Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Medicinal Mushroom Market Insights Video

Competitive Landscape of the Medicinal Mushroom Market

The market for medicinal mushrooms is extremely competitive, and major players include Hokkaido Reishi, Banken Champignons B.V., Far West Fungi, Swadeshi Mushroom, and Gourmet Mushrooms Ltd. These businesses provide a variety of mushroom supplements in the form of capsules, powders, and extracts and concentrate on product creation driven by research. The potency of bioactive substances, organic certifications, sourcing methods, and quality all influence competition. In order to attract health-conscious customers, market leaders place a strong emphasis on openness, sustainable sourcing, and stringent testing. In order to gain market share, new competitors also take advantage of e-commerce sites and increased consumer interest in functional foods, which makes rivalry in this quickly developing sector more fierce.

In September 2024, Applied Food Sciences, Inc. (AFS) announced the establishment of a new, cutting-edge cultivation facility in Finland as part of the extension of its strategic cooperation with KÄÄPÄ Biotech. This development reflects the companies' shared commitment to creating the best Nordic-origin mushrooms and responds to the growing demand for premium medicinal mushrooms globally. (Source: https://appliedfoods.com/afs-and-kaapa-biotech-build-new-cultivation-facility/ ) In December 2021, Psyence Group Inc. stated that it has teamed with "vida e caffè," one of Africa's biggest coffee retail chains, to launch its GOODMINDTM functional mushroom brand in a few of its coffee shops in South Africa. (Source: https://psyence.com/2021/12/02/psyence-group-functional-mushroom-brand-goodmind-commences-national-roll-out-in-south-africas-largest-coffee-retail-chain/) In August 2021, Leading international psychedelics firm Silo Wellness Inc. signed a statewide distribution arrangement with Essex-based LocoSoco Group Plc, a U.K. brand distributor, in accordance with a distribution agreement dated August 4, 2021. LocoSoco is designated as the sole distributor of Silo Wellness' whole line of Marley One-branded mushroom products in the United Kingdom by the Distribution Agreement. (Source: https://silowellness.com/press-release/silo-wellness-brings-marley-one-mushrooms-to-the-u-k-market-through-distribution-agreement-with-locosoco-limited/)

Top Companies Market Share in Medicinal Mushroom Industry: (In no particular order of Rank)

• Hokkaido Reishi
• Banken Champignons B.V.
• Far West Fungi
• Swadeshi Mushroom
• Gourmet Mushrooms Ltd.
• DXN Holdings
• MahaGro India
• Nikkei Marketing Limited
• Chaga Mountain
• Inc.
• Asia Pacific Farm Enterprises Inc.
• Concord Farms
• SSD Mushrooms.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Medicinal Mushroom Market

Which Region Dominates the Medicinal Mushroom Market in 2024?

According to Cognitive Market Research, North America currently dominates the Medicinal Mushrooms market, and the region is expected to have significant growth during the projected period. The market for medicinal mushrooms is expanding in North America due to increasing consumer enthusiasm for therapeutic foods and herbal supplements. Due to consumer desire for products that improve immunity and cognitive function, the US leads the market. Turkey Tail, Lion's Mane, and Reishi mushrooms are well-liked because of their alleged health advantages. Additionally, Canada exhibits consistent growth, with a robust organic and wellness industry that complements medicinal mushrooms. Growing retail and e-commerce channels are facilitating accessibility in both nations and product innovation is sparked by studies on the health advantages of mushrooms. Possibilities exist in producing premium, organic-certified goods that satisfy consumer demands for potency and purity.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Traditional customs and contemporary health trends are driving the thriving Asia-Pacific medicinal mushroom industry. The market is dominated by China and Japan, whose traditional medicine has traditionally used mushrooms like shiitake, cordyceps, and reishi. Due to its wealth of cultivation resources and knowledge, China is a significant producer and exporter. Research and innovation are prioritized in Japan, particularly in the fields of functional foods and supplements. With growing customer interest in natural health goods, South Korea and India also contribute to growth. While e-commerce and wellness trends generate additional growth potential, growing markets throughout the area are supported by growing knowledge of the immunological and cognitive benefits of mushrooms.

The current report Scope analyzes Medicinal Mushroom Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Medicinal Mushroom

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 14085.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Medicinal Mushroom market with a market size of USD 11113.70 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Demand is being increased by consumers' increased attention to immunity and health, particularly in the wake of COVID-19. The US industry is still expanding due to the popularity of wellness products and natural supplements.
• The Canada Medicinal Mushroom market had a market share of USD 1690.30 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Demand is being driven by the wellness industry's growing preference for organic, plant-based supplements as well as consumers' growing interest in functional foods as they relate to their health.
• The Mexico Medicinal Mushroom market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1281.81 million in 2024.

Europe Medicinal Mushroom

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 10564.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom Medicinal Mushroom market had a market share of USD 1774.81 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. The demand is supported by a robust market for natural, nutritional foods and supplements, particularly in UK cities where consumers place a high value on mental and immunological health.
• The France Medicinal Mushroom market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 971.92 million in 2024.
• According to Cognitive Market Research, the German Medicinal Mushroom market size was valued at USD 2091.74 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. The need for medicinal mushrooms, particularly for goods related to immunological and cognitive health, is supported by Germany's robust nutraceutical and functional food markets as well as its high level of knowledge of preventative healthcare.
• The Italy Medicinal Mushroom market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 908.53 million in 2024.
• The Russian Medicinal Mushroom market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 1637.47 million in 2024.
• The Spain Medicinal Mushroom market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 866.28 million in 2024
• The Luxembourg Medicinal Mushroom market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 327.49 million in 2024.
• The Portugal Medicinal Mushroom market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 221.85 million in 2024.
• The Greece Medicinal Mushroom market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 126.77 million in 2024.
• The Rest of Europe's Medicinal Mushroom market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1637.47 million in 2024.

Asia Pacific Medicinal Mushroom

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 8099.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Medicinal Mushroom market size was valued at USD 3644.70 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Traditional Chinese medicine relies heavily on medicinal mushrooms, and the demand for goods like Reishi and Cordyceps in the food, pharmaceutical, and supplement industries is driven by growing health consciousness.
• The Japan Medicinal Mushroom market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 1117.71 million in 2024.
• The India Medicinal Mushroom market had a market share of USD 971.92 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. Demand is influenced by rising middle-class demand for natural supplements and growing awareness of wellness and preventive health. The advantages of medicinal mushrooms in India are in line with the market for herbal remedies and Ayurveda.
• The South Korean Medicinal Mushroom market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 809.93 million in 2024.
• The Australian Medicinal Mushroom market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 421.17 million in 2024.
• The South East Asia Medicinal Mushroom market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 558.85 million in 2024.
• The Rest of Asia Pacific Medicinal Mushroom market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 575.05 million in 2024.

South America Medicinal Mushroom

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 1760.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Medicinal Mushroom market size was valued at USD 753.59 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. One important factor is the growing acceptance of natural health products and alternative treatment among urban dwellers. In Brazil, interest in organic products and immune-boosting vitamins is rising.
• Argentina's Medicinal Mushroom market had a market share of USD 295.80 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Interest in natural supplements is growing due to rising health consciousness and the need for immunological support, especially in Argentina's urban areas where wellness trends are common.
• Colombia Medicinal Mushroom market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 156.70 million in 2024.
• Peru Medicinal Mushroom market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 144.38 million in 2024.
• Chile's Medicinal Mushroom market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 126.77 million in 2024.
• The Rest of Latin America's Medicinal Mushroom market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 283.48 million in 2024.

Middle East Medicinal Mushroom

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 704.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031..

• The GCC Countries Medicinal Mushroom market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 301.44 million in 2024. In GCC countries, demand is driven by an increasing emphasis on health and well-being as well as an increased knowledge of alternative medicines, particularly in high-income markets like the UAE and Saudi Arabia.
• The Egypt Medicinal Mushroom market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 73.95 million in 2024.
• The South Africa Medicinal Mushroom market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 111.28 million in 2024. A growing interest in herbal medicine and health consciousness supports the demand for medicinal mushrooms. In South African cities that prioritize wellness, mushrooms are being utilized more and more as natural health supplements and to boost the immune system.
• The Turkey Medicinal Mushroom market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 60.57 million in 2024.
• The Nigeria Medicinal Mushroom market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 73.95 million in 2024.
• The Rest of the MEA Medicinal Mushroom market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 83.11 million in 2024.

Medicinal Mushroom Market Analysis

How are Segments Performing in the Global Medicinal Mushroom Market?

Medicinal Mushroom Market Type Segment Analysis

According to Cognitive Market Research, Reishi is likely to dominate the Medicinal Mushroom Market over the forecast period. Reishi mushrooms are highly sought-after because of their many health advantages, especially their anti-inflammatory, stress-relieving, and immune-boosting properties. In traditional Chinese medicine, reishi is referred to as the "mushroom of immortality" and is valued for its adaptogenic properties, which aid in stress management and enhance general health. This demand is driven by rising consumer interest in immune-boosting and natural health products, particularly in the wake of the pandemic. Available in supplements, powders, and functional beverages, Reishi is popular in both traditional and modern wellness markets. Consumption is further supported by its use in anti-ageing and holistic health products, which propels its expansion in the global medicinal mushroom market.

The Maitake is the fastest-growing segment in the Medicinal Mushroom Market. Because of their renowned health benefits, especially in blood sugar regulation and immunological support, maitake mushrooms are becoming more and more popular. Known as the "dancing mushroom," maitake has long been utilized in Chinese and Japanese medicine for its ability to strengthen the heart, reduce inflammation, and boost immunity. Maitake is frequently used in nutritional supplements, functional foods, and drinks due to the increased consumer interest in natural, plant-based wellness solutions. Its popularity in the medicinal mushroom market, particularly in North America and Asia, is further fostered by its reputation for fostering general vitality as well as new research into its ability to combat cancer.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Medicinal Mushroom Industry. Request a Free Sample PDF!

Medicinal Mushroom Market Form Segment Analysis

According to Cognitive Market Research, the Fresh segment holds the largest share of the market. Fresh medicinal mushrooms are becoming more and more in demand as shoppers look for natural, unprocessed health items. The whole range of bioactive substances, such as polysaccharides and antioxidants, that exist in fresh mushrooms like shiitake, maitake, and reishi are prized because they are frequently more effective when eaten in their natural state. Fresh medicinal mushrooms are often used in cooking, especially in Asian cooking, where they improve the taste and nutritional value of soups and other foods. Fresh mushrooms are also preferred by people who want to feel their therapeutic benefits directly and comprehensively. A wider desire for fresh, organic, and minimally processed meals is reflected in this expanding trend.

In the Medicinal Mushroom Market, Dried has been expanding at a rapid pace. The need for dried medicinal mushrooms has been influenced by the global trend toward natural health products, as well as the growing popularity of adaptogens and immune-boosting supplements. Dried medicinal mushrooms are especially popular in markets like North America and Asia, where consumers seek both traditional and modern wellness solutions. Due to their extended shelf life, convenience, and concentrated health benefits, dried medicinal mushrooms are in high demand. The bioactive compounds in mushrooms like Reishi, Chaga, and Cordyceps are preserved by drying, making them an appealing option for consumers seeking easy-to-store supplements and functional meals.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Medicinal Mushroom Function Outlook: Segment Analysis

Medicinal Mushroom Market Function Segment Analysis

According to Cognitive Market Research, the Immune Enhancer segment holds the largest market share. Due to increasing awareness among customers of the significance of immune health, especially in the wake of the COVID-19 epidemic, there is a fast-increasing market for medicinal mushrooms that boost immunity. Beta-glucans and polysaccharides are the main ingredients that give mushrooms like reishi, turkey tail, and maitake their potent immune-boosting qualities. These mushrooms are being utilized more and more in functional foods, pills, and drinks that are said to boost immunity and ward off disease. As people look for alternatives to traditional medicine, the market is growing due to the increased desire for natural, plant-based remedies. In North America, Europe, and Asia, where health-conscious customers value optimal health, this trend is especially significant.

In the Medicinal Mushroom market, the rapidly growing sector is Anti-Cancer. Growing public interest in natural, alternative medicines, in addition to traditional cancer treatments, is driving a steady increase in demand for anti-cancer medicinal mushrooms. Reishi, Shiitake, Maitake, and Turkey Tail mushrooms are thought to have anti-cancer qualities because of their high polysaccharide, antioxidant, and bioactive chemical content. These mushrooms are frequently used in extracts and supplements meant to boost immunity, lower inflammation, and stop the formation of tumours. Consumer confidence is also being bolstered by research on their efficacy in treating and preventing cancer. The international demand for these medicinal mushrooms is being encouraged by a stronger focus on cancer prevention and natural healing.

• Antioxidant
• Immune Enhancer
• Anti-Cancer
• Skin Care
• Others

Medicinal Mushroom Distribution Channel Outlook: Segment Analysis

Medicinal Mushroom Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the Pharmacies segment dominates the market. Because more people are interested in natural health supplements, pharmacies are experiencing an increase in demand for medicinal mushroom products. As consumers look for anti-ageing, immune-boosting, and general wellness advantages, pharmacists are adding medicinal mushrooms like lion's mane, cordyceps, and reishi to their inventory. Usually, these products come in extracts, powders, and capsule forms. Consumers are increasingly looking to pharmacies for dependable, superior mushroom supplements, particularly ones that are certified organic, according to trends. In order to increase their market share in the wellness sector, pharmacies are also leveraging the trend of personalized health by providing products based on mushrooms that target particular health issues.

Retail Stores are projected to be the fastest-growing segment in the Medicinal Mushroom market. The appetite for medicinal mushroom products in stores is rising as people look for natural wellness solutions and become more health-conscious. Capsules, powders, and teas of mushrooms like Reishi, Chaga, and Lion's Mane are becoming more and more popular as the popularity of nutritious food, supplements, and personal care items grows. In response, retailers are adding premium medicinal mushrooms that are organic to their product lines. Retail establishments are turning into important distribution channels as their health advantages—such as immunological support, cognitive improvement, and anti-inflammatory qualities—become more widely known. Pharmacies, supermarket chains, and health food stores are where this tendency is most noticeable.

• Pharmacies
• Retail Stores
• E-commerce
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion